Welcome to the annual anti-inflammatory version of The Dry Eye.
You are probably wondering what the heck there is to say about the anti-inflammatory world, especially after my epic multi-column/blog post rant earlier this year. Frankly, so am I. Consequently, this could very well be one of my shorter columns. I mean, short of just saying we are all waiting for the reproxalap Prescription Drug User Fee Act date in December, there is not a whole heck of a lot going on.
On the other hand, I rarely know where (Read more...)